EXPERIMENTAL VACCINE FOR COVID-19 BY OXFORD UNIVERSITY RESEARCHERS,UK

Dear my friends and fellow Colleagues, Here is an update on AZD1222, Vaccine for COVID-19 developed by Oxford University Researchers along with Researchers from SII, Serum Institute of India funded by UK Pharma Giant Astra Zeneca. An experimental Coronavirus Vaccine-AZD1222 developed by AstraZeneca & Oxford University Shows promising results in producing double immune response in form of Antibody production & T cell response. It has shown only minor adverse effects like Headache & Fever. Early clinical trial of 1077 adults. Lancet,July2020. SII, Serum institute India is likely to start clinical trials of Oxford Vaccine in August, 2020. Several Pharma Giant Companies are in the battle all over the world including Bharat Vaccines, Hyderabad, India. Let's wait and watch who wins the race. Huge money is involved in this Research and Bill Gates, Microsoft, USA is behind every Pharma Giant in the world in the quest of COVID-19 Vaccine, need less to say the ultimate winner is Bill Gates who ever comes out with a successful Vaccine against COVID-19. Regards and thanks, Dr Sepuri Krishna Mohan.

16 Likes

LikeAnswersShare
A great achievement for Serum Institute of India,- making its presence felt in collaboration with Oxford University researchers. Definitely- AZD1222 vaccine will provide a hope for the continuous surge of COVID-19 cases inIndia and the world. Thanks Dr Sepuri krishna Mohan for the update
Valuable opinion
0
just have few questions for Oxford university: what if the vaccine given in positive asymptomatic patient? and is it like,if the vaccine is taken, how long will its effect remain? a vaccinated person if work in covid icu, how much r the chances of him getting positive?
These are very tough to answer and premature too because we are in the process of understanding COVID-19. Nothing so far is neither documented nor Evidence Based Medicine
1
Yes very encouraging news best part is no serious adverse effects are seen In india human trial is launched and in couple of months data and results will be out First dose on zero day 2nd dose on 14th day If all goes well than booster will be designed
Valuable opinion
0
A very heartening news. Especially the information that the immunity given by this vaccine is likely to last for years, because of effect on killer T cells. Thanks for sharing,Sir
Valuable opinion
0
Such encouraging and positive news admist all the havoc of covid 19. Thank you for the update, sir.
You're most welcome dear Beti Namrata
1
Bharat biotak is starting abv157 vaccine for public use from August 2020 as icmr report6
Valuable opinion
0

View 1 other reply

Sir what are chances of India pharma win?
Let's be optimistic, wait and watch
0

View 1 other reply

Interesting much needed
Valuable opinion
0

Cases that would interest you